Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
+23.91%
3Y annualised
-0.67% 1D
NAV: 15 Jun '26
₹37.12
Min. for SIP
₹100
Fund size (AUM)
₹950.31 Cr
Expense ratio
1.21%
Rating
2
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 6 months | ₹30,000 | ₹32,063 | +6.88% | |
| 1 year | ₹60,000 | ₹64,750 | +7.92% | |
| 3 years | ₹1,80,000 | ₹2,22,465 | +23.59% | |
| 5 years | ₹3,00,000 | ₹4,58,874 | +52.96% |
Holdings (40)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.42% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 7.31% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 4.75% |
| JB Chemicals & Pharmaceuticals Ltd | Healthcare | Equity | 4.73% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 4.37% |
| Ajanta Pharma Ltd | Healthcare | Equity | 3.99% |
| Mankind Pharma Ltd. | Healthcare | Equity | 3.89% |
| Lupin Ltd | Healthcare | Equity | 3.73% |
| Abbott India Ltd | Healthcare | Equity | 3.65% |
| Fortis Healthcare Ltd | Healthcare | Equity | 3.31% |
| Reverse Repo | Unspecified | Reverse Repo | 3.23% |
| Emcure Pharmaceuticals Ltd. | Healthcare | Equity | 3.17% |
| Cipla Ltd | Healthcare | Equity | 2.98% |
| Shilpa Medicare Ltd | Healthcare | Equity | 2.92% |
| Ipca Laboratories Ltd | Healthcare | Equity | 2.43% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 2.26% |
| Procter & Gamble Health Ltd | Healthcare | Equity | 2.24% |
| CORONA Remedies Ltd. | Healthcare | Equity | 2.06% |
| Alkem Laboratories Ltd | Healthcare | Equity | 2.03% |
| Thyrocare Technologies Ltd | Healthcare | Equity | 1.89% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | Equity | 1.84% |
| Divi's Laboratories Ltd | Healthcare | Equity | 1.82% |
| Metropolis Healthcare Ltd | Healthcare | Equity | 1.57% |
| Sanofi Consumer Healthcare India Ltd | Healthcare | Equity | 1.52% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 1.38% |
| Pfizer Ltd | Healthcare | Equity | 1.36% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 1.36% |
| Alembic Pharmaceuticals Ltd | Healthcare | Equity | 1.25% |
| Biocon Ltd | Healthcare | Equity | 1.23% |
| Gland Pharma Ltd | Healthcare | Equity | 1.20% |
| Piramal Pharma Ltd | Healthcare | Equity | 1.16% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 1.13% |
| Vijaya Diagnostic Centre Ltd | Healthcare | Equity | 1.08% |
| Medi Assist Healthcare Services Ltd. | Industrials | Equity | 1.01% |
| Suraksha Diagnostic Ltd. | Healthcare | Equity | 1.01% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 0.75% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 0.71% |
| Jubilant Pharmova Ltd | Healthcare | Equity | 0.66% |
| Vinati Organics Ltd | Materials | Equity | 0.65% |
| Net Payables | Unspecified | Net Payables | -0.05% |
See All
Minimum investments
Min. for 1st investment
₹1,000
Min. for 2nd investment
₹1,000
Min. for SIP
₹100
Returns and rankings
Annualised returns
Absolute returns
| Name | 1Y | 3Y | 5Y | All |
|---|---|---|---|---|
| Fund returns | +11.7% | +23.9% | +14.0% | +20.8% |
| Category average (Equity Sectoral) | -2.1% | +22.1% | +14.6% | -- |
| Rank (Equity Sectoral) | 9 | 5 | 7 | -- |
Exit load, stamp duty and tax
Exit load
Exit load of 1% if redeemed within 30 days.
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
DSDhaval ShahJun 2019 - PresentView details
DS
Dhaval Shah
Jun 2019 - Present
View details
About Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Aditya Birla Sun Life Mutual Fund. This scheme was made available to investors on 23 Dec 1994. Dhaval Shah is the Current Fund Manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹4,13,736 Cr and the Latest NAV as of 15 Jun 2026 is ₹37.12.
The Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹1,000. Exit load of 1% if redeemed within 30 days.
;
Investment Objective
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
Fund benchmarkBSE Healthcare Total Return Index
Fund house
Rank (total assets)#4 in India
Total AUM₹4,13,735.69 Cr
Date of Incorporation23 Dec 1994
Launch Date23 Dec 1994
AddressOne World Center, Tower 1, 17th Floor, Jupiter Mill CompoundSenapati Bapat Marg, Elphinstone Road Mumbai 400013
Websitewww.camsonline.com
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,